ALTO vs. PFE
ALTO (Alto Ingredients, Inc.) and PFE (Pfizer Inc.) are both stocks. ALTO operates in Specialty Chemicals (Basic Materials), while PFE operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, ALTO returned -1.54%/yr vs 1.85%/yr for PFE. At a 0.12 correlation, their price movements are largely independent.
Performance
ALTO vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ALTO achieves a 92.01% return, which is significantly higher than PFE's 5.18% return. Over the past 10 years, ALTO has underperformed PFE with an annualized return of -1.54%, while PFE has yielded a comparatively higher 1.85% annualized return.
ALTO
- 1D
- -2.47%
- 1M
- 1.10%
- YTD
- 92.01%
- 6M
- 97.50%
- 1Y
- 482.53%
- 3Y*
- 37.87%
- 5Y*
- -1.68%
- 10Y*
- -1.54%
PFE
- 1D
- -0.82%
- 1M
- -2.06%
- YTD
- 5.18%
- 6M
- 2.42%
- 1Y
- 16.11%
- 3Y*
- -7.32%
- 5Y*
- -3.51%
- 10Y*
- 1.85%
ALTO vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ALTO Alto Ingredients, Inc. | 92.01% | 84.62% | -41.35% | -7.64% | -40.12% | -11.42% | 735.38% | -24.51% | -81.08% | -52.11% |
PFE Pfizer Inc. | 5.18% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Correlation
The correlation between ALTO and PFE is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Aug 14, 2012 | 0.12 |
Fundamentals
ALTO:
$423.81M
PFE:
$145.22B
ALTO:
$0.38
PFE:
$1.31
ALTO:
14.40
PFE:
19.31
ALTO:
0.00
PFE:
0.35
ALTO:
0.46
PFE:
2.28
ALTO:
$916.07M
PFE:
$63.32B
ALTO:
$45.94M
PFE:
$43.91B
ALTO:
$20.37M
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALTO vs. PFE — Risk / Return Rank
ALTO
PFE
ALTO vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alto Ingredients, Inc. (ALTO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ALTO | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.39 | ||
| Sortino ratioReturn per unit of downside risk | +3.30 | ||
| Omega ratioGain probability vs. loss probability | 1.64 | 1.14 | +0.50 |
| Calmar ratioReturn relative to maximum drawdown | 17.00 | 1.41 | +15.59 |
| Martin ratioReturn relative to average drawdown | 39.94 | 2.91 | +37.02 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ALTO | PFE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 5.07 | 0.68 | +4.39 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.02 | -0.14 | +0.12 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.02 | 0.08 | -0.10 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.21 | 0.23 | -0.44 |
Drawdowns
ALTO vs. PFE - Drawdown Comparison
The maximum ALTO drawdown since its inception was -99.99%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for ALTO and PFE.
Loading charts...
Drawdown Indicators
| ALTO | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -58.96% | -41.03% |
Max Drawdown (1Y)Largest decline over 1 year | -28.62% | -11.47% | -17.15% |
Max Drawdown (3Y)Largest decline over 3 years | -84.11% | -40.75% | -43.36% |
Max Drawdown (5Y)Largest decline over 5 years | -89.12% | -58.96% | -30.16% |
Max Drawdown (10Y)Largest decline over 10 years | -97.77% | -58.96% | -38.81% |
Current DrawdownCurrent decline from peak | -99.88% | -47.49% | -52.39% |
Average DrawdownAverage peak-to-trough decline | -92.32% | -17.68% | -74.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.16% | 5.54% | +6.62% |
Volatility
ALTO vs. PFE - Volatility Comparison
Alto Ingredients, Inc. (ALTO) has a higher volatility of 30.02% compared to Pfizer Inc. (PFE) at 4.07%. This indicates that ALTO's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALTO | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.02% | 4.07% | +25.95% |
Volatility (6M)Calculated over the trailing 6-month period | 68.58% | 14.64% | +53.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 95.99% | 23.85% | +72.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 79.46% | 25.49% | +53.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 90.65% | 23.88% | +66.77% |
Dividends
ALTO vs. PFE - Dividend Comparison
ALTO has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.79%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALTO Alto Ingredients, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.79% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
ALTO vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Alto Ingredients, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALTO vs. PFE - Profitability Comparison
ALTO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alto Ingredients, Inc. reported a gross profit of 9.22M and revenue of 224.68M. Therefore, the gross margin over that period was 4.1%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
ALTO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alto Ingredients, Inc. reported an operating income of 2.52M and revenue of 224.68M, resulting in an operating margin of 1.1%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
ALTO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alto Ingredients, Inc. reported a net income of 3.96M and revenue of 224.68M, resulting in a net margin of 1.8%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
ALTO and PFE have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALTO has higher volatility (30.02%) compared to PFE (4.07%). In terms of maximum drawdown, ALTO dropped -99.99% vs PFE's -58.96%.
ALTO currently has the higher Sharpe Ratio (5.07 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALTO and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer